- Previous close
168.71 - Open
169.83 - Bid 173.66 x 800
- Ask 180.00 x 800
- Day's range
168.52 - 170.54 - 52-week range
94.57 - 171.35 - Volume
779,071 - Avg. Volume
760,356 - Market cap (intra-day)
22.865B - Beta (5Y monthly) 0.70
- PE ratio (TTM)
53.21 - EPS (TTM)
3.19 - Earnings date 29 Oct 2024
- Forward dividend & yield 1.60 (0.94%)
- Ex-dividend date 16 Dec 2024
- 1y target est
176.49
Leidos Holdings, Inc., together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S. Intelligence Community, the Department of Defense, the space development agency, the National Aeronautics and Space Administration, defense information systems agency, military services, and government agencies of U.S. allies abroad, as well as other federal and commercial customers in the national security industry. The solutions include technology, large-scale systems, command and control platforms, data analytics, logistics, and cybersecurity solutions, as well as intelligence analysis and operations support services to critical missions. The Civil segment provides systems integration services to air navigation service providers, including the federal aviation administration, the En route automation modernization, advanced technology oceanic procedure, time based flow management, terminal flight data management, geo-7, and future flight services, as well as enterprise-information display systems; and security detection services. It also offers information technology (IT) solutions in cloud computing, mobility, application modernization, DevOps, data center, network modernization, asset management, help desk operations, and digital workplace enablement; and environment, energy, and infrastructure services. The Health segment offers solutions to federal and commercial customers responsible for health and well-being of people, include health information management, managed health, digital modernization, and life sciences research and development services. Leidos Holdings, Inc. was founded in 1969 and is headquartered in Reston, Virginia.
www.leidos.com47,000
Full-time employees
29 December
Fiscal year ends
Technology
Sector
Information Technology Services
Industry
Recent news: LDOS
View morePerformance overview: LDOS
Trailing total returns as of 28/10/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: LDOS
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: LDOS
View moreValuation measures
Market cap
22.86B
Enterprise value
27.20B
Trailing P/E
53.21
Forward P/E
17.86
PEG ratio (5-yr expected)
--
Price/sales (ttm)
1.46
Price/book (mrq)
5.13
Enterprise value/revenue
1.70
Enterprise value/EBITDA
22.24
Financial highlights
Profitability and income statement
Profit margin
2.72%
Return on assets (ttm)
7.69%
Return on equity (ttm)
9.63%
Revenue (ttm)
16.01B
Net income avi to common (ttm)
436M
Diluted EPS (ttm)
3.19
Balance sheet and cash flow
Total cash (mrq)
823M
Total debt/equity (mrq)
114.46%
Levered free cash flow (ttm)
1.23B